
HEADLINE: Kenyan Court Blocks $2.5 Billion U.S. Health Deal Over Data Privacy Fears
DATELINE: NAIROBI, May 15, 2024
A Kenyan High Court has issued an order halting a major $2.5 billion health sector agreement with the United States, citing profound concerns over the potential exposure and transfer of citizens’ sensitive medical data abroad.
The ruling, delivered this week, comes after a petition by the Consumer Federation of Kenya (COFEK), a consumer rights group. COFEK argued that the agreement’s provisions could allow for the sharing of personal health records outside the country, putting privacy at risk and potentially leaving Kenya without control over its own health data systems.
Judge Justice Mixeo Kiprono granted an interim injunction, specifically blocking any implementation of the deal’s data-sharing components until the case is fully heard and determined.
The contested agreement is part of a new U.S. global health strategy that bypasses traditional multilateral organizations to establish direct government-to-government health partnerships. Similar pacts have been signed with other African nations, including Rwanda, Lesotho, Liberia, and Uganda.
In Kenya, however, the deal has sparked significant public anxiety. Activists and citizens have expressed fears that the arrangement could grant U.S. entities access to highly confidential medical information, including individuals’ HIV status, tuberculosis treatment history, and vaccination records.
“This isn’t just about data; it’s about the sovereignty of our health systems and the fundamental right to privacy for every Kenyan,” a representative for COFEK stated following the court’s decision. “We cannot trade our most intimate details for funding.”
The U.S. government has previously framed these direct agreements as a more efficient way to bolster partner countries’ health infrastructure, combat diseases, and improve healthcare delivery. The U.S. Embassy in Nairobi has not yet issued a formal statement on the court’s injunction.
The Kenyan Ministry of Health, a signatory to the deal, now faces mounting pressure to clarify the exact data protocols involved and to ensure robust legal safeguards are in place. The court’s intervention underscores the growing global tension between the pursuit of vital health funding and the imperative to protect digital privacy and national control over critical data.
The case is scheduled for a full hearing in the coming weeks, where the government will be expected to defend the agreement’s data protection measures.








